Cidara Therapeutics Inc. (CDTX)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

22.88

-1.59%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	63.91M	64.29M	49.57M	12.07M	20.91M	-	-	-	-	-	-	-
Cost of Revenue	1.52M	143.00K	189.00K	68.02M	46.40M	523.00K	667.00K	732.00K	461.00K	-	-	-
Gross Profit	62.38M	64.14M	49.38M	-55.95M	-25.49M	-523.00K	-667.00K	-732.00K	-461.00K	-	-	-
Operating Income	-24.48M	-29.72M	-42.26M	-71.85M	-41.72M	-63.28M	-55.72M	-48.44M	-32.31M	-11.62M	-1.08M	-792.00K
Interest Income	2.00M	191.00K	212.00K	262.00K	221.00K	-	-	-	-	-	-	-
Pretax Income	-22.49M	-29.53M	-42.47M	-72.11M	-41.09M	-59.02M	-55.73M	-48.16M	-32.19M	-11.89M	-1.34M	-792.00K
Net Income	-22.93M	-29.80M	-43.91M	-72.37M	-40.09M	-59.02M	-55.73M	-48.16M	-32.19M	-11.89M	-1.34M	-792.00K
Selling & General & Admin	18.33M	18.49M	18.74M	15.90M	16.24M	14.14M	12.90M	12.74M	8.84M	3.31M	272.00K	780.00K
Research & Development	68.53M	75.52M	73.09M	68.02M	46.40M	49.14M	42.82M	35.70M	23.48M	6.71M	810.00K	12.00K
Other Expenses	-	-	-	-	-	-211.00K	-	-	-	-183.00K	-167.00K	-
Operating Expenses	86.86M	94.01M	91.83M	83.92M	62.64M	63.28M	55.72M	48.44M	32.31M	10.02M	1.08M	792.00K
Interest Expense	-	191.00K	212.00K	262.00K	221.00K	629.00K	7.00K	271.00K	120.00K	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	88.39M	94.01M	91.83M	83.92M	62.64M	63.28M	55.72M	48.44M	32.31M	10.02M	1.08M	792.00K
Income Tax	443.00K	272.00K	1.44M	262.00K	-1.01M	4.27M	-667.00K	-732.00K	-461.00K	1.70M	-987.00K	-
Shares Outstanding (Basic)	4.37M	3.49M	2.62M	2.08M	1.50M	1.29M	875.04K	724.45K	688.48K	40.99K	16.18K	17.72K
Shares Outstanding (Diluted)	4.37M	3.49M	2.62M	2.08M	1.50M	1.29M	875.04K	724.45K	688.48K	40.99K	16.18K	3.12M
EPS (Basic)	-5.25	-8.53	-16.75	-34.83	-26.78	-45.62	-63.69	-66.49	-46.76	-290.15	-83.04	-44.7
EPS (Diluted)	-5.25	-8.53	-16.74	-34.83	-26.78	-45.62	-63.69	-66.49	-46.76	-290.15	-83.04	-0.25
EBITDA	-24.36M	-33.36M	-42.26M	-71.56M	-41.40M	-62.76M	-55.72M	-47.70M	-31.85M	-9.84M	-1.08M	-
Depreciation & Amortization	118.00K	143.00K	189.00K	286.00K	328.00K	523.00K	667.00K	732.00K	461.00K	179.00K	1.08M	792.00K